Curanex Pharmaceuticals, Inc. (CURX)
4.77
-0.22
(-4.41%)
USD |
NASDAQ |
Oct 07, 16:00
4.76
-0.01
(-0.21%)
Pre-Market: 20:00
Curanex Pharmaceuticals Net Income (Quarterly) : -3.291M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.291M |
| March 31, 2026 | -3.150M |
| December 31, 2025 | -3.073M |
| September 30, 2025 | -0.9541M |
| June 30, 2025 | -0.0603M |
| March 31, 2025 | -0.1376M |
| Date | Value |
|---|---|
| December 31, 2024 | -0.1372M |
| September 30, 2024 | -0.0999M |
| June 30, 2024 | -0.0442M |
| March 31, 2024 | -0.0802M |
| December 31, 2023 | -0.0127M |
| September 30, 2023 | 0.00 |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Resonate Blends, Inc. | -0.9669M |
| Kaya Holdings, Inc. | -8.592M |
| Endexx Corp. | -1.288M |
| Earth Science Tech, Inc. | 0.7157M |
| Eco-Growth Strategies, Inc. | -0.159M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.291M |
| EPS Diluted (Quarterly) | -2.320 |
| Enterprise Value | 4.103M |
| Earnings Yield | -154.8% |
| Normalized Earnings Yield | -154.83 |